• Complain

Richard A. Smith - Neurotherapeutics in the Era of Translational Medicine

Here you can read online Richard A. Smith - Neurotherapeutics in the Era of Translational Medicine full text of the book (entire story) in english for free. Download pdf and epub, get meaning, cover and reviews about this ebook. City: London, year: 2020, publisher: Academic Press, genre: Science. Description of the work, (preface) as well as reviews are available. Best literature library LitArk.com created for fans of good reading and offers a wide selection of genres:

Romance novel Science fiction Adventure Detective Science History Home and family Prose Art Politics Computer Non-fiction Religion Business Children Humor

Choose a favorite category and find really read worthwhile books. Enjoy immersion in the world of imagination, feel the emotions of the characters or learn something new for yourself, make an fascinating discovery.

No cover

Neurotherapeutics in the Era of Translational Medicine: summary, description and annotation

We offer to read an annotation, description, summary or preface (depends on what the author of the book "Neurotherapeutics in the Era of Translational Medicine" wrote himself). If you haven't found the necessary information about the book — write in the comments, we will try to find it.

For the first time in history, there is now hope for treating neurological disorders that had previously been considered untreatable. The remarkable confluence of events that has heralded this is the focus of Neurotherapeutics in the Era of Translational Medicine. This anthology, written by many of the prominent scientists and researchers in the field of biotechnology, recounts the breathtaking advances that are revolutionizing treatment for disorders such as amyotrophic lateral sclerosis, spinal muscular atrophy, multiple sclerosis, Parkinsons disease, myasthenia gravis, migraine, and glioblastoma. The story behind the story of these translational efforts is told, with authors depicting the ups and downs encountered on the path of their drug discovery and development effort. In parallel with this path, advances in identifying novel biomarkers and disease models are summarized, as are contemporary issues focusing on clinical trial design, bioethics, innovative funding strategies, and collaborations between government and academia in an effort to facilitate breakthrough treatments. The book is written by members of the biotech and pharmaceutical ecosystem for those who belong to it and aspire to become part of it.

Richard A. Smith: author's other books


Who wrote Neurotherapeutics in the Era of Translational Medicine? Find out the surname, the name of the author of the book and a list of all author's works by series.

Neurotherapeutics in the Era of Translational Medicine — read online for free the complete book (whole text) full work

Below is the text of the book, divided by pages. System saving the place of the last page read, allows you to conveniently read the book "Neurotherapeutics in the Era of Translational Medicine" online for free, without having to search again every time where you left off. Put a bookmark, and you can go to the page where you finished reading at any time.

Light

Font size:

Reset

Interval:

Bookmark:

Make
Copyright Academic Press is an imprint of Elsevier 125 London Wall London - photo 1
Copyright

Academic Press is an imprint of Elsevier

125 London Wall, London EC2Y 5AS, United Kingdom

525 B Street, Suite 1650, San Diego, CA 92101, United States

50 Hampshire Street, 5th Floor, Cambridge, MA 02139, United States

The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, United Kingdom

2021 Elsevier Inc. All rights reserved.

No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval system, without permission in writing from the publisher. Details on how to seek permission, further information about the Publishers permissions policies and our arrangements with organizations such as the Copyright Clearance Center and the Copyright Licensing Agency, can be found at our website: www.elsevier.com/permissions.

This book and the individual contributions contained in it are protected under copyright by the Publisher (other than as may be noted herein).

Notices

Knowledge and best practice in this field are constantly changing. As new research and experience broaden our understanding, changes in research methods, professional practices, or medical treatment may become necessary.

Practitioners and researchers must always rely on their own experience and knowledge in evaluating and using any information, methods, compounds, or experiments described herein. In using such information or methods they should be mindful of their own safety and the safety of others, including parties for whom they have a professional responsibility.

To the fullest extent of the law, neither the Publisher nor the authors, contributors, or editors, assume any liability for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein.

Library of Congress Cataloging-in-Publication Data

A catalog record for this book is available from the Library of Congress

British Library Cataloguing-in-Publication Data

A catalogue record for this book is available from the British Library

ISBN 978-0-12-816475-4

For information on all Academic Press publications visit our website at https://www.elsevier.com/books-and-journals

Publisher Nikki Levy Acquisitions Editor Melanie Tucker Editorial Project - photo 2

Publisher: Nikki Levy

Acquisitions Editor: Melanie Tucker

Editorial Project Manager: Kristi Anderson

Production Project Manager: Punithavathy Govindaradjane

Cover Designer: Matthew Limbert

Typeset by SPi Global, India

Contributors

Karen Aboody Department of Developmental and Stem Cell Biology, Beckman Research Institute of City of Hope, Duarte, CA, United States

Olubankole Aladesuyi Arogundade Department of Neurosciences, University of California at San Diego, La Jolla, CA, United States

Giovanni Appendino Department of Pharmaceutical Sciences, University of Eastern Piedmont, Novara, Italy

Weiqi Bao PET Center, Huashan Hospital, Fudan University, Shanghai, China

Marco A.S. Baptista The Michael J. Fox Foundation for Parkinson's Research, New York, NY, United States

Danielle Beaulieu Origent Data Sciences, Inc., Vienna, VA, United States

Frank Bennett Ionis Pharmaceuticals, Carlsbad, CA, United States

Emma Brand Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease, McCance Center for Brain Health, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, United States

Don Cleveland Ludwig Institute at the University of California, San Diego, La Jolla, CA, United States

Stanley L. Cohan Providence Multiple Sclerosis Center, Providence Brain and Spine Institute, Portland, OR, United States

Jonavelle Cuerdo Origent Data Sciences, Inc., Vienna, VA, United States

Jim DeMesa Emerald Health Pharmaceuticals, San Diego, CA, United States

David L. Ennist Origent Data Sciences, Inc., Vienna, VA, United States

Meryem Guler Cogent Family Healthcare, Mountain View, CA, United States

Nada Hindiyeh Department of Neurology, Stanford University, Stanford, CA, United States

Hanna Hovren Center for Neurologic Study, La Jolla, CA, United States

Yiyun Henry Huang PET Center, Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT, United States

Hongmei Jia Ministry of Education Key Laboratory of Radiopharmaceuticals, College of Chemistry, Beijing Normal University, Beijing, China

Jie Jiang Department of Cell Biology, Emory University, Atlanta, GA, United States

Brian K. Kaspar Milo Biotechnology, San Diego, CA, United States

Petra Kaufmann VC R&D Translational Medicine R&D, AveXis, A Novartis Company, San Diego, CA, United States

Randall Kaye Center for Neurologic Study, La Jolla, CA, United States

Jeffery W. Kelly

Department of Chemistry

The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA, United States

Mike Keymer Origent Data Sciences, Inc., Vienna, VA, United States

Doo Yeon Kim Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease, McCance Center for Brain Health, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, United States

Kiren Kresa-Reahl Atara Biotherapeutics Inc., Thousand Oaks, CA, United States

Ikjae Lee Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, United States

Melanie Leitner Accelerating NeuroVentures, LLC, Boston, MA, United States

Stefanie N. Linch Cancer Early Detection Advanced Research Center (CEDAR), Knight Cancer Institute, Oregon Health and Science University, Portland, OR, United States

Elisabeth B. Lucassen Providence Multiple Sclerosis Center, Providence Brain and Spine Institute, Portland, OR, United States

Timothy Miller Department of Neurology, Washington University in St. Louis-School of Medicine, St. Louis, MO, United States

Rachael Mooney Department of Developmental and Stem Cell Biology, Beckman Research Institute of City of Hope, Duarte, CA, United States

Gaetano Morello Emerald Health Naturals, Vancouver, BC, Canada

Eduardo Muoz

Emerald Health Pharmaceuticals, San Diego, CA, United States

Maimonides Biomedical Research Institute of Crdoba (IMIBIC)

Department of Cellular Biology, Physiology and Immunology, University of Crdoba

University Hospital Reina Sofa, Crdoba, Spain

Michael Murray Emerald Health Naturals, Vancouver, BC, Canada

Hoi Wa Ngai Department of Developmental and Stem Cell Biology, Beckman Research Institute of City of Hope, Duarte, CA, United States

Joseph Park Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease, McCance Center for Brain Health, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, United States

Dustin Pierce Origent Data Sciences, Inc., Vienna, VA, United States

Jana Portnow Department of PS Medical Oncology, Beckman Research Institute of City of Hope, Duarte, CA, United States

Evan T. Powers Department of Chemistry, The Scripps Research Institute, La Jolla, CA, United States

Luisa Quinti Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease, McCance Center for Brain Health, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, United States

Next page
Light

Font size:

Reset

Interval:

Bookmark:

Make

Similar books «Neurotherapeutics in the Era of Translational Medicine»

Look at similar books to Neurotherapeutics in the Era of Translational Medicine. We have selected literature similar in name and meaning in the hope of providing readers with more options to find new, interesting, not yet read works.


Reviews about «Neurotherapeutics in the Era of Translational Medicine»

Discussion, reviews of the book Neurotherapeutics in the Era of Translational Medicine and just readers' own opinions. Leave your comments, write what you think about the work, its meaning or the main characters. Specify what exactly you liked and what you didn't like, and why you think so.